Sells hemp-derived cannabinoid supplements, functional wellness products and beverages to consumers, retailers and distributors.
10-K for FY2025, filed Dec 19, 2025cbdMD, Inc. is a consumer wellness company focused on the development, manufacturing, marketing, and sale of supplement brands powered by…View ↗
We operate a multi-brand portfolio anchored by our flagship cbdMD® line, which offers oils, gummies, capsules, soft-gels, topicals…View ↗
Our ATRX® platform offers cutting edge, emerging and novel non-cannabinoid functional ingredients such as functional mushrooms and supports…View ↗
Our Herbal Oasis (“Oasis”) brand is a premium hemp-derived THC-infused social seltzer that blends cannabinoids and nootropic mushrooms to…View ↗
Our products are sold through a diversified distribution network that includes direct-to-consumer e-commerce platforms, online…View ↗
Consumers typically pay before online orders ship; wholesale buyers generally pay after the sale, with timing set by the applicable agreement.
10-K for FY2025, filed Dec 19, 2025
$19.2M
10-K for FY2025, filed Dec 19, 2025
$19.2M ↗
Consumers buy through the company’s websites and phone sales, while retailers and distributors buy through the inside sales team for resale in stores and online.
10-K for FY2025, filed Dec 19, 2025We distribute our products both through our online sales channel as well as through a number of wholesalers and retailers that resell our…View ↗
No. It lost $2M in FY2025.
10-Q for Q3 FY2026, filed Aug 13, 2026
−$1.1MView ↗
8-K, filed Sep 2, 2026
On September 1, 2026, cbdMD, Inc. (the “Company”) entered into an Asset Purchase Agreement (the “Asset Purchase Agreement”) by and among…View ↗
8-K, filed Jan 14, 2026
On January 12, 2026 (the “Closing”), cbdMD, Inc., a North Carolina corporation (the “Company”) and Gaia Botanicals, LLC, a Colorado limited…View ↗
Shrinking. Revenue fell 57% in 4 years, from $44.5M in FY2021 to $19.2M in FY2025, about 19% a year.
New product categories
The portfolio has expanded beyond CBD brands and products to include functional mushroom supplements and hemp-derived THC beverages, alongside its cbdMD and Paw CBD lines.
10-K for FY2022, filed Dec 15, 2022 10-K for FY2025, filed Dec 19, 2025We own and operate the nationally recognized CBD (cannabidiol) brands cbdMD, Paw CBD and cbdMD Botanicals. We believe that we are an…View ↗
Our cbdMD brand of products includes an array of high-grade, premium every day and functional CBD products, including tinctures; gummies…View ↗
Our Paw CBD brand of products includes a line of veterinarian-formulated products including tinctures, chews, topicals products in varying…View ↗
We operate a multi-brand portfolio anchored by our flagship cbdMD® line, which offers oils, gummies, capsules, soft-gels, topicals…View ↗
Our ATRX® platform offers cutting edge, emerging and novel non-cannabinoid functional ingredients such as functional mushrooms and supports…View ↗
Our Herbal Oasis (“Oasis”) brand is a premium hemp-derived THC-infused social seltzer that blends cannabinoids and nootropic mushrooms to…View ↗
Loading...